je.st
news
Tag: biopharma
6th Annual BIO CEO and Investor Conference to Feature Fireside Chats Between Biopharma CEOs ...
2013-12-12 06:00:00| Industrial Newsroom - All News for Today
Scheduled for Feb 10–11, 2014, 16th annual BIO CEO & Investor Conference will include Fireside Chats featuring set of candid, one-on-one conversations between biopharma leaders and analysts, followed by interactive question and answer session. Five CEOs participating in 2014 Fireside Chats include Leonard Bell, M.D., of Alexion Pharmaceuticals, Inc.; Belén Garijo, M.D., of Merck Serono; Richard F. Pops of Alkermes plc; David E.I. Pyott of Allergan; and Christopher A. Viehbacher of ...This story is related to the following:Trade Associations
Tags: feature
annual
conference
bio
Galena Biopharma Receives New Coverage from Analysts at Oppenheimer
2013-11-27 00:45:43| Biotech - Topix.net
The firm set an "outperform" rating and a $6.00 price target on the stock. Oppenheimer's price target suggests a potential upside of 63.49% from the stock's previous close.
Tags: coverage
receives
analysts
oppenheimer
Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
2013-10-30 06:00:00| Industrial Newsroom - All News for Today
Genedata Biologics™ will be implemented at multiple Sanofi RD sites and departments to improve biologics discovery throughput and process efficiency<br /> <br /> Basel, Switzerland -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Sanofi, a leading global healthcare company, has chosen Genedata Biologics as its data management platform for biologics screening activities. The first-in-class enterprise system ...This story is related to the following:Scientific Software | Data Analysis Software |
Tags: support
process
integrated
adopts
ARCA Biopharma Announces IND Submission To US FDA For Gencaro For The Treatment Of Atrial Fibrillation
2013-10-30 03:30:20| drugdiscoveryonline News Articles
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for the GENETIC-AF clinical trial of Gencaro (bucindolol hydrochloride), a pharmacologically unique beta-blocker and mild vasodilator being developed for atrial fibrillation (AF)
Tags: treatment
submission
ind
announces
KBI Biopharma Selects Freeslate's Biologics Formulation System For Early And Late Stage Drug Development
2013-09-04 06:58:35| drugdiscoveryonline News Articles
Freeslate, Inc., the leading provider of high throughput research solutions, today announced that KBI Biopharma, Inc. (KBI), a leading development and contract manufacturing organization serving the biopharmaceutical industry, has purchased Freeslate’s Biologics Formulation System to help develop more robust formulations using less time and material
Tags: system
development
early
late
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »